相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Case-Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors
Anna Kanerva et al.
MOLECULAR THERAPY (2015)
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy
Otto Hemminki et al.
ONCOTARGET (2015)
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
Ilkka Liikanen et al.
ONCOIMMUNOLOGY (2015)
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders
O. Hemminki et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
Anna Kanerva et al.
CLINICAL CANCER RESEARCH (2013)
[18F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer
Anniina Koski et al.
HUMAN GENE THERAPY (2013)
Penton-Dodecahedral Particles Trigger Opening of Intercellular Junctions and Facilitate Viral Spread during Adenovirus Serotype 3 Infection of Epithelial Cells
Zhuo-Zhuang Lu et al.
PLOS PATHOGENS (2013)
Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
Otto Hemminki et al.
MOLECULAR THERAPY (2012)
Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
Petri Nokisalmi et al.
CLINICAL CANCER RESEARCH (2010)
分享论文
